Gothenburg, Sweden

Mattias Münnich

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Pergamum Ab. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mattias Münnich. Retrieved from https://idiyas.com/inventor/mattias-münnich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mattias Münnich: Innovator in Pharmaceutical Compositions

Introduction

Mattias Münnich is a notable inventor based in Göteborg, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at enhancing healing processes.

Latest Patents

Münnich holds a patent for "Hyaluronic acid containing compositions for prevention of the formation of post-surgical scars and post-surgical adhesions." This invention relates to pharmaceutical compositions that enhance the therapeutic effect of biologically active peptides, especially those derived from human lactoferrin. The compositions are particularly useful for the treatment and prevention of wounds, scars, and post-surgical adhesions. He has 1 patent to his name.

Career Highlights

Throughout his career, Münnich has worked with various companies, including Pergamum AB and Pharmasurgics in Sweden AB. His work has focused on innovative solutions that address critical medical challenges.

Collaborations

Münnich has collaborated with notable colleagues such as Margit Mahlapuu and Veronika Sjöstrand, contributing to advancements in his field.

Conclusion

Mattias Münnich's work in pharmaceutical compositions showcases his commitment to improving medical treatments and patient outcomes. His innovative approach continues to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…